IGMS

IGM Biosciences
IGMS

Delisted

IGMS was delisted on the 13th of August, 2025.

89 hedge funds and large institutions have $316M invested in IGM Biosciences in 2022 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 31 increasing their positions, 26 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less funds holding

Funds holding:

less ownership

Funds ownership:

11% less first-time investments, than exits

New positions opened: 17 | Existing positions closed: 19

35% less capital invested

Capital invested by funds: $487M → $316M (-$172M)

Holders
89
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2M
Puts
$252K
Net Calls
Net Calls Change

Top Sellers

1 -$10.8M
2 -$7.98M
3 -$5.75M
4
Goldman Sachs
Goldman Sachs
New York
-$4.14M
5
WP
Woodline Partners
California
-$3.67M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$60.1M
2
$56.9M
3
$47.3M
4
$36.1M
5
$18.6M
6
$13M
7
$10.6M
8
$9.67M
9
$9.21M
10
$4.95M
11
$4.56M
12
$3.61M
13
$3.58M
14
$3.55M
15
$3.38M
16
$2.79M
17
$2.25M
18
$1.99M
19
$1.83M
20
$1.58M
21
$1.47M
22
$1.3M
23
$1.27M
24
$1.18M
25
$991K